Håkan Wallin, B.Sc., CEFA, Chairman
Håkan comes most recently from a position as Executive Vice President Corporate Development at Medivir AB. His previous experience includes being a partner and head of life sciences at ABG Sundal Collier AB's Corporate Finance Department, and a board member and CEO at Libertas Capital Nordic AB. 
Håkan currently works as an independent consultant for his own consulting firm, HWA Advisory & Capital AB, and is also a member of the board at LightLab Sweden AB.

Per Langö, M.Sc., Board member.
Mr. Lango has extensive industry experience from the global pharmaceutical and medical device industry with focus on marketing and sales, product development and business development. 
He is currently Head of M&A, Nestlé Skin Health and has previously held senior positions at Galderma and Q-Med.
Gunvor Ekman Ordeberg, M.D., Ph.D. Board member
Gunvor  currently serves as a professor of obstetrics and gynecology at Karolinska Institutet as well as senior physician. Her group of 30 members has conducted translational research in obstetrics and gynecology. 
Her publication list includes more than 150 publications research focused upon preterm birth (PTB), protracted labor and the innervation of reproductive tract. In addition to Pharmanest, Dr. Ekman-Ordeberg is a founder of Dilafor AB. 
She received her M.D. from the University of Uppsala/Lund in 1972 and Ph.D. at the University of Lund in 1982.  
Carl-Johan Spak, PhD., Board member
Executive Vice President at Recipharm AB. Prior to joining Recipharm Dr. Spak has been Director Nordic Region of Meda. He previously held positions of increasing responsibility including Managing Director and Vice President with Recip AB since 1995. 
Dr. Spak also serves as board member in several companies, among them Cobra Biologics Holding AB, Kahr Medical Ltd (Israel), Prokarium Ltd (UK), Symcel Sverige AB, XSpray AB, Synthonics Inc (US).

Dr. Spak graduated with a Dentist degree 1980 and received his Ph.D. 1984 from Karolinska Institutet, Sweden.